Journal of Cancer Research and Therapeutics Close
 

Table 2: Outcomes of Grade 3 or 4 drug-related adverse events for other regimens therapy versus capecitabine chemotherapy

Table 2: Outcomes of Grade 3 or 4 drug-related adverse events for other regimens therapy versus capecitabine chemotherapy